HINOVA PHARMACEUTICALS INC.

Other languages Hinova Pharmaceuticals Inc.

Equities

688302

CNE1000059F5

End-of-day quote Shanghai S.E. Other stock markets 18:00:00 2024-06-19 EDT			5-day change	1st Jan Change
27.04 ^CNY	-0.37%		-4.32%	-48.07%

04-26	Hinova Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-08	China Stocks Fall Ahead of March Economic Data Release	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Hinova Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-26
China Stocks Fall Ahead of March Economic Data Release	04-08
Hinova Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02-23
Hinova Pharmaceuticals Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27
Hinova Pharmaceuticals Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30
Hinova Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27
Hinova Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27
Hinova Receives FDA Proceed Authorization for its IND Application for HP518, an Orally Bioavailable Chimeric Degrader Targeting Androgen Receptor for Prostate Cancer Treatment	23-02-06
Hinova Disclosed the Preclinical Results of HP518 (Oral AR PROTAC) at the 5th Annual TPD Summit	22-10-28
Hinova Pharmaceuticals Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27
Hinova Pharmaceuticals Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Our Free Content Help you Secure and Increase the Performance of Your Investments

Securing my Investments

fermer